cycloprolol
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Oct 1, 2023 (NCT06046638)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- Beta-1 adrenergic receptorINHIBITOR
ADRB1 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)NCC(O)COc1ccc(OCCOCC2CC2)cc1- Mol. weight
- 323.43 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2110772 ↗
- ChEMBLCHEMBL2105976 ↗
Also known as
- cicloprolol
- cicloprolol
- cicloprolol
- cicloprolol
- cicloprolol
- cicloprolol hcl
- cicloprolol hydrochloride
- cycloprolol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06046638 | Phase 4 | Oct 1, 2023 | Haisco Pharmaceutical, Jiao Tong University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Haisco Pharmaceutical | For profit | 1 | 0 | 1 | 2023 |
| Jiao Tong University | Academic/Hospital | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1